Pelican-Cancer-Foundation-logos
Donate Now
Search
Pelican-Cancer-Foundation-logos

Dedicated to helping patients with bowel and liver cancer live well for longer

Donate Now
Search
  • Home
  • About us
    • About us
    • What we do
      • Our achievements
      • The Future
    • Who we are
      • Trustees
      • Our Team
      • Patrons
      • Annual Accounts
    • Partnerships
    • Vacancies
    • News
  • Education
    • Pelican OReCO
      • OReCO On-line Resources
      • OReCO Partners & Sponsors
      • Pelican OReCO Workshops
    • Pelican IMPACT
      • IMPACT – Completion & Evaluation
      • Workshops
      • IMPACT – Online resources
      • IMPACT – Partners and Sponsors
    • SPECC
      • SPECC – Completion & Evaluation
      • Workshops
      • SPECC – Online resources
      • SPECC – Partners and Sponsors
    • LOREC
    • TIPTOP
      • Workshops
      • TIPTOP – Online resources
      • Bob’s story (prostate cancer)
      • Andrew’s story (prostate cancer)
      • Alan’s story (prostate cancer)
      • Raymond’s story (prostate cancer)
    • LARS
    • Sponsors
      • Become a sponsor
    • Request a course or topic
    • Give us feedback
    • Previous courses
  • Films
  • Research
    • MERCURY 3
    • Research strategy
    • Bowel cancer research
      • POLARS
      • MERCURY 2 (Low Rectal Cancer Study)
      • Deferral of surgery study
      • TATME
      • IMPRESS
      • TRIGGER
      • Papers of interest
      • Timing of surgery
      • AMSOEC
      • MINSTREL
      • Completed research
        • Perineal wound healing registry
        • Beyond TME
        • Validation of the LARS score
        • MARVEL: Evaluation of EMVI positive rectal cancer
        • FLEX
        • TME Physical Simulation Model
        • Total Mesorectal Excision (TME)
        • MERCURY research programme
    • Liver cancer research
      • Completed research
        • EORTC studies
      • SERENADE
      • Papers of interest
    • Peritoneal malignancy research
      • Colorectal Peritoneal Malignancy Database
      • Pseudomyxoma Pathology Atlas
    • Previous Research Areas
      • Prostate Cancer Research
        • Prostate cancer
        • Focal therapy and HIFU research
        • MRI research for prostate cancer
        • Prostate cancer colloquiums
        • FORECAST
        • Trachtomap
        • Papers of interest
      • Bladder cancer research
        • Bladder cancer
        • Papers of interest
    • Peer reviewers
    • Clinical trials
    • Information for research applicants
      • Peer Review Panel Terms of Reference
      • Research Review Panel
      • Research Grant Application Guidance Notes
      • Terms and conditions of grants
      • Animals in medical research
      • Research costs
    • Surgical videos
  • For Patients
    • Patient stories
      • Anthony’s story (bowel cancer)
      • Elena’s story (bowel cancer)
      • Terry’s story (liver cancer)
      • Derrick’s story (liver cancer)
      • Alex’s story (colorectal cancer)
      • Cheryll’s story (rectal cancer)
      • Eileen’s story
      • Richard’s story – irrigation
      • Tom’s story – complete response
      • Advanced metastatic bowel cancer
    • What is an MDT?
      • What an MRI reveals
      • Reporting cancer outcomes
    • Bowel cancer
      • Our bowel cancer team
      • About bowel cancer treatment – TME
      • April – Bowel Cancer Awareness Month
      • Low rectal cancer
      • Complete response to chemoradiotherapy in rectal cancer
      • Frequently asked questions about bowel cancer
      • Irrigation for colostomies
      • A patient’s advice
      • Symptom checker
      • Bowel cancer – useful contacts
    • Liver cancer
      • Our liver cancer team
      • About liver cancer treatment
      • Interventional radiology
      • Liver cancer – frequently asked questions
      • Carcinoid and neuroendocrine tumours
      • Liver cancer – want to read more?
    • Pseudomyxoma peritonei
    • Getting a second opinion
    • Clinical trials
      • Current clinical trials
    • Tell us your story
    • Still got questions about cancer?
    • Links
  • Support us
    • Make a donation
      • Make a donation
      • Shares
      • In memory
    • Fundraise for us
      • Our fundraisers
      • Fundraising ideas
      • Fundraising challenges
      • Fundraising resources
    • Leave a Gift in your Will
    • Become a Corporate Partner
    • Trusts, Foundations & Philanthropy
    • Tell us your story
  • Contact us

Our achievements

 

Today, the life expectancy and quality of life for many bowel cancer patients is greatly improved than what it was just 10 years ago. Eighty percent of cases can be successfully treated if diagnosed early, often by surgery.

 

Conferences and workshops, forging change to improve patient outcome. Through its educational programmes, Pelican brings healthcare professionals together to discuss, share experiences and learn from others. Continued learning is essential to share the latest advances in treatment, technology and surgical treatments to embed best practice and knowledge.

Pelican’s National Education Programmes since 2003:

  1. MDT-TME (Multi-Disciplinary Team – Total Mesorectal Excision) Programme 2003-2007
  2. LOREC (Low Rectal Cancer) Development Programme 2009-2012
  3. SPECC (Significant Polyp and Early Colorectal Cancer) Programme 2014-2017
  4. IMPACT (Improving Management for Patients with Advanced Colorectal Tumours) 2018-2020
  5. OReCO (Optimising Rectal Cancer Outcomes) Programme 2024 – 2026

Pelican has pioneered groundbreaking work in the field of education and research which has changed clinical practice across the world, and with your support we are determined to continue in our goal to improve the care and treatment of patients with bowel cancer.

 

Symposium Photo

Since 2001, more than 8,000 clinicians have attended Pelican training courses and meetings. Pelican has hosted several crucial meetings for clinical experts including several Guidelines Meetings, contributing to setting national standards for cancer diagnosis and treatment.

Since 2002, Pelican has invested in medical research for bowel cancer. Our first major research project, MERCURY, assessed the role of MRI (magnetic resonance imaging) in accurately detecting and planning surgery for bowel cancer. Pelican has championed this use of MRI through its courses – and today it is recommended best practice for rectal cancer patients to have an MRI before surgery in the UK.

Pelican is currently working with Prof Gina Brown, Prof Brendan Moran and Miss Amy Lord to develop and deliver MERCURY 3 which is a futuristic study, further refining the use of MRI to stage cancers in patients with rectal cancer. Click here to find out more.

With your help, Pelican can continue to save and improve the lives of those with bowel cancer.

Stay in touch

Sign up to hear from us
Donate Now

© 2023 Pelican Cancer Foundation - all rights reserved

  Registered Charity Number: 1141911 -  Privacy Policy